TCS AgentHub: AI for Drug Development & Efficiency

TCS has launched a new platform called TCS ADD AgentHub. This platform helps pharmaceutical companies use agentic artificial intelligence, or AI, in drug development. This includes areas like clinical trials and pharmacovigilance. Here's the thing: The platform lets companies use AI agents in clinical development and drug safety, all while maintaining human oversight and meeting regulatory rules. Pharmaceutical companies often struggle with applying AI due to large amounts of data and complex regulations. AgentHub offers a framework with defined roles for AI agents, oversight, and built-in auditability. What's interesting is that companies can build their own AI agent hub and deploy agents across various clinical workflows. The platform integrates easily with existing systems. It supports tasks like safety report intake, data entry, coding, and literature analysis. It also helps with study design and clinical data review. TCS reports that solutions powered by this platform have shown up to 40% efficiency gains in clinical data management. They also saw up to a 30% reduction in clinical study build effort. The platform can deliver up to 30% cost savings in safety case processing, and AI-powered safety agents can cut quality control effort by up to 50%. The platform uses a "Human + AI Operating Model," where AI agents work within existing processes, and humans handle governance and decisions. This matters because it could significantly accelerate drug development and improve patient safety.